Skip to main content
. 2020 Oct 22;2020:3520764. doi: 10.1155/2020/3520764

Figure 3.

Figure 3

Forest plots of rs1799782 (Arg194Trp) and clinical outcomes in NSCLC patients under platinum-based chemotherapy. (a) ORR in the dominant model. (b) ORR in the recessive model. (c) OS in the homozygous model. NSCLC: non-small-cell lung cancer; ORR: objective response rate; OS: overall survival.